Page last updated: 2024-11-11

clavaric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

clavaric acid: inhibits farnesyl-protein transferase; isolated from Clavariadelphus truncatus; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6918349
CHEMBL ID452658
SCHEMBL ID8897544
MeSH IDM0297545

Synonyms (8)

Synonym
clavaric acid
2-alpha-(3''-hydroxy-3''-methylglutaroyl)-24,25-dihydroxylanostan-3-one
bdbm50250718
CHEMBL452658 ,
5-[[(2r,5r,10s,13r,14r,17r)-17-[(2r)-5,6-dihydroxy-6-methylheptan-2-yl]-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,7,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-2-yl]oxy]-3-hydroxy-3-methyl-5-oxopentanoic acid
SCHEMBL8897544
Q15410870
DTXSID001045451
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)IC50 (µMol)0.82500.00050.471610.0000AID73411; AID73412
Protein farnesyltransferase subunit betaHomo sapiens (human)IC50 (µMol)0.82500.00050.21772.5000AID73411; AID73412
Integrase Human immunodeficiency virus 1IC50 (µMol)66.00000.00051.544310.0000AID356545; AID356546
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (9)

Processvia Protein(s)Taxonomy
transforming growth factor beta receptor signaling pathwayProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
protein farnesylationProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
protein geranylgeranylationProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
positive regulation of Rac protein signal transductionProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
skeletal muscle acetylcholine-gated channel clusteringProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
positive regulation of tubulin deacetylationProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
positive regulation of deacetylase activityProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
positive regulation of skeletal muscle acetylcholine-gated channel clusteringProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
lipid metabolic processProtein farnesyltransferase subunit betaHomo sapiens (human)
protein farnesylationProtein farnesyltransferase subunit betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
protein farnesyltransferase activityProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
protein farnesyltransferase activityProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
protein geranylgeranyltransferase activityProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
Rab geranylgeranyltransferase activityProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
protein bindingProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
microtubule bindingProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
receptor tyrosine kinase bindingProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
alpha-tubulin bindingProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
molecular adaptor activityProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
CAAX-protein geranylgeranyltransferase activityProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
protein farnesyltransferase activityProtein farnesyltransferase subunit betaHomo sapiens (human)
protein farnesyltransferase activityProtein farnesyltransferase subunit betaHomo sapiens (human)
protein bindingProtein farnesyltransferase subunit betaHomo sapiens (human)
zinc ion bindingProtein farnesyltransferase subunit betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
cytosolProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
plasma membraneProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
CAAX-protein geranylgeranyltransferase complexProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
microtubule associated complexProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
protein farnesyltransferase complexProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
cytoplasmProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
cytosolProtein farnesyltransferase subunit betaHomo sapiens (human)
microtubule associated complexProtein farnesyltransferase subunit betaHomo sapiens (human)
protein farnesyltransferase complexProtein farnesyltransferase subunit betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (25)

Assay IDTitleYearJournalArticle
AID73412Inhibition of human Farnesyltransferase using Ras-CVLS1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
AID73117Inhibition of human Farnesyltransferase1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
AID403824Inhibition of squalene synthase1998Journal of natural products, Dec, Volume: 61, Issue:12
Clavaric acid: a triterpenoid inhibitor of farnesyl-protein transferase from Clavariadelphus truncatus.
AID403827Cytotoxicity against mouse NIH/3T3 cells at 50 uM1998Journal of natural products, Dec, Volume: 61, Issue:12
Clavaric acid: a triterpenoid inhibitor of farnesyl-protein transferase from Clavariadelphus truncatus.
AID86400Inhibition of cholesterol biosynthesis in HepG2 cells at 16 uM1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
AID73112Inhibition of human Farnesyltransferase1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
AID356546Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay2003Journal of natural products, Oct, Volume: 66, Issue:10
Chemistry and structure-activity relationship of HIV-1 integrase inhibitor integracide B and related natural products.
AID73116Inhibition of human Farnesyltransferase1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
AID73429Inhibition of human Farnesyltransferase1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
AID73428Inhibition of human Farnesyltransferase1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
AID73113Inhibition of human Farnesyltransferase1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
AID356545Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay2003Journal of natural products, Oct, Volume: 66, Issue:10
Chemistry and structure-activity relationship of HIV-1 integrase inhibitor integracide B and related natural products.
AID74622inhibition of human Geranylgeranyl transferase using Ras-CVIM1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
AID403823Inhibition of human recombinant protein farnesyl transferase expressed in Escherichia coli1998Journal of natural products, Dec, Volume: 61, Issue:12
Clavaric acid: a triterpenoid inhibitor of farnesyl-protein transferase from Clavariadelphus truncatus.
AID86561Inhibition of cholesterol biosynthesis in HepG2 cells at 81 uM1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
AID73115Inhibition of human Farnesyltransferase1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
AID356553Inhibition of DNAse2003Journal of natural products, Oct, Volume: 66, Issue:10
Chemistry and structure-activity relationship of HIV-1 integrase inhibitor integracide B and related natural products.
AID86559Inhibition of cholesterol biosynthesis in HepG2 cells at 32 uM1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
AID74621Inhibition of human Geranylgeranyl transferase using Ras-CAIL1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
AID73430Inhibition of human Farnesyltransferase1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
AID403826Inhibition of Ras expression in mouse NIH/3T3 cells at 50 uM1998Journal of natural products, Dec, Volume: 61, Issue:12
Clavaric acid: a triterpenoid inhibitor of farnesyl-protein transferase from Clavariadelphus truncatus.
AID403825Inhibition of geranylgeranyl protein transferase1998Journal of natural products, Dec, Volume: 61, Issue:12
Clavaric acid: a triterpenoid inhibitor of farnesyl-protein transferase from Clavariadelphus truncatus.
AID73411Inhibition of human Farnesyltransferase using Ras-CVIM1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
AID73114Inhibition of human Farnesyltransferase1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
AID356552Inhibition of Escherichia coli ECOR12003Journal of natural products, Oct, Volume: 66, Issue:10
Chemistry and structure-activity relationship of HIV-1 integrase inhibitor integracide B and related natural products.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's5 (71.43)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.18

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.18 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.18)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]